Bray George, Gregg Edward, Haffner Steven, Pi-Sunyer Xavier F, WagenKnecht Lynne E, Walkup Michael, Wing Rena
Pennington Biomedical Research Center, Baton Rouge, LA 70808, USA.
Diab Vasc Dis Res. 2006 Dec;3(3):202-15. doi: 10.3132/dvdr.2006.031.
The Look AHEAD (Action for Health in Diabetes) study is a 16-centre randomised clinical trial in overweight and obese individuals with type 2 diabetes, designed to evaluate the long-term effects (up to 11.5 years) of intensive weight loss intervention on the time to incidence of major cardiovascular events.
Eligibility requirements are diagnosis of type 2 diabetes (determined by self-report and verification) in individuals aged 4574 years and body mass index (BMI) > 25 kg/m2 (> 27 kg/m2 if currently taking insulin). The intensive lifestyle intervention is designed to achieve and maintain weight loss through decreased caloric intake and increased physical activity. The study is designed to provide 90% probability of detecting an 18% difference in major cardiovascular disease event rates in patients randomised to the intensive lifestyle intervention compared to the control group receiving standard diabetes support and education.
The 5,145 participants who were randomised between 2001 and 2004 were 63.3% white, 15.6% African-American, 13.2% Hispanic, 5.0% American Indian and 1.0% Asian-American, which closely paralleled the ethnic distribution of diabetes in the National Health and Nutrition Examination Survey (NHANES) 1999-2000 survey. Their average age at entry was 59+/-6.8 years (mean+/-SD), and 60% were women. There were 31.5% between 4555 years of age, 51.5% were 5665, and 17.0% were 6676 years of age. Some 15.4% of participants were taking insulin at the time of randomisation and 14.0% had a history of cardiovascular disease. More men (21.3%) than women (9.2%) had a history of cardiovascular disease. Few participants (4.4%) were current cigarette smokers, compared to 16.2% in the NHANES 1999-2000 survey. Furthermore, 65.0% of participants had a first-degree relative with diabetes. Overall, BMI averaged 36+/-5.9 kg/m2 at baseline, with 83.6% of the men and 86.1% of women having a BMI > 30 kg/m2 and 17.9% of men and 25.4% of women having a BMI > 40 kg/m2.
The Look AHEAD study has successfully randomised a large cohort of participants who have type 2 diabetes with a wide distribution of age, obesity, ethnicity and racial background and will examine the effects of lifestyle intervention on the incidence of major cardiovascular events.
“展望未来(糖尿病健康行动)”研究是一项在超重和肥胖的2型糖尿病患者中开展的16中心随机临床试验,旨在评估强化体重减轻干预对主要心血管事件发病时间的长期影响(长达11.5年)。
入选标准为年龄在45 - 74岁、体重指数(BMI)> 25 kg/m²(如果目前正在使用胰岛素则BMI > 27 kg/m²)且经自我报告和验证确诊为2型糖尿病的个体。强化生活方式干预旨在通过减少热量摄入和增加体力活动来实现并维持体重减轻。该研究旨在提供90%的概率,以检测随机分配到强化生活方式干预组的患者与接受标准糖尿病支持和教育的对照组相比,主要心血管疾病事件发生率有18%的差异。
在2001年至2004年期间随机分组的5145名参与者中,63.3%为白人,15.6%为非裔美国人,13.2%为西班牙裔,5.0%为美国印第安人,1.0%为亚裔美国人,这与1999 - 2000年全国健康和营养检查调查(NHANES)中糖尿病的种族分布情况非常相似。他们入组时的平均年龄为59 ± 6.8岁(均值 ± 标准差),60%为女性。年龄在45 - 55岁之间的占31.5%,56 - 65岁之间的占51.5%,66 - 76岁之间的占17.0%。约15.4%的参与者在随机分组时正在使用胰岛素,14.0%有心血管疾病史。有心血管疾病史的男性(21.3%)多于女性(9.2%)。与1999 - 2000年NHANES调查中16.2%的比例相比,当前吸烟者很少(4.4%)。此外,65.0%的参与者有一位患糖尿病的一级亲属。总体而言,基线时BMI平均为36 ± 5.9 kg/m²,83.6%的男性和86.1%的女性BMI > 30 kg/m²,17.9%的男性和25.4%的女性BMI > 40 kg/m²。
“展望未来”研究成功地将一大群患有2型糖尿病、年龄、肥胖程度、种族和民族背景分布广泛的参与者进行了随机分组,并将研究生活方式干预对主要心血管事件发生率的影响。